A Phase I/II Study to Evaluate the Safety and Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis
Clinical trial NCT02313883 · COMPLETED
Trial details
- NCT number
- NCT02313883
- Sponsor
- Geistlich Pharma AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-07-02
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.